Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Rapid diagnostics industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Purchase trends
2.1.5 Technology/platform trends
2.1.6 Distributional Channel trends
2.1.7 End-use trends
Chapter 3 Rapid Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1. Increasing prevalence of infectious disease
3.2.1.2 Technological advancements
3.2.1.3 Increasing popularity of rapid diagnostic tests
3.2.1.4 Rising awareness regarding early diagnosis among People
3.2.1.5 Increasing government initiatives for the diagnosis of infectious diseases
3.2.2 Industry pitfalls & challenges
3.2.2.1 Low accuracy of results
3.2.2.2 Availability of substitute product
3.2.2.3 Stringent regulatory framework
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By purchase
3.3.3 By technology/platform
3.3.4 By distribution channel
3.3.5 By end-use
3.4 COVID-19 impact analysis
3.5 Technology landscape
3.6 Future market trends
3.7 Gap analysis
3.8 Regulatory landscape
3.8.1 U.S.
3.8.2 Europe
3.9 Reimbursement scenario
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Company market share analysis, 2022
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Rapid Diagnostics Market Size and Forecast, By Product (USD Million)
5.1 Key product trends
5.1.1 Infectious Disease Testing
5.1.1.1 Respiratory Infection Testing Products
5.1.1.2 Influenza
5.1.1.3 Hepatitis
5.1.1.4 HIV
5.1.1.5 Others
5.1.2 Glucose Monitoring
5.1.3 Cardiometabolic Testing
5.1.4 Coagulation testing products
5.1.5 Pregnancy and Fertility Testing
5.1.6 Tumor/Cancer marker testing products
5.1.7 Urinalysis testing products
5.1.8 Cholesterol testing products
5.1.9 Hematology testing products
5.1.10 Drug-of-Abuse (DoA) testing products
5.1.11 Fecal occult testing products
Chapter 6 Rapid Diagnostics Market Size and Forecast, By Purchase (USD Million)
6.1 Key purchase trends
6.1.1 OTC
6.1.2 Prsecription
Chapter 7 Rapid Diagnostics Market Size and Forecast, By Technology/Platform (USD Million)
7.1 Key technology/platform trends
7.1.1 Flow-Through
7.1.2 Solid Phase
7.1.3 Lateral Flow
7.1.4 Agglutination Assays
7.1.5 Others
Chapter 8 Rapid Diagnostics Market Size and Forecast Market, By Distribution Channel (USD Million)
8.1 Key distribution channel trends
8.1.1 Hospital Pharmacies
8.1.2 Brick & Mortar
8.1.3 E-commerce
8.1.4 Others
Chapter 9 Rapid Diagnostics Market Size and Forecast Market, By End-use (USD Million)
9.1 Key end-use trends
9.1.1 Diagnostic Centers
9.1.2 Homecare Settings
9.1.3 Hospital Pharmacies
9.1.4 Others
Chapter 10 Rapid Diagnostics Market Size and Forecast Market , By Region (USD Million)
10.1 Key regional trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Poland
10.3.7 Switzerland
10.3.8 The Netherlands
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Indonesia
10.4.7 Thailand
10.4.8 Philippines
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Columbia
10.5.5 Chile
10.5.6 Peru
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Egypt
10.6.5 Iran
10.6.6 Israel
Chapter 11 Company Profiles
11.1 Abbott
11.2 Roche
11.3 Danaher Corporation (HemoCue & Radiometer)
11.4 Quidel Corporation
11.5 Bio-Rad Laboratories
11.6 ACON Laboratories Inc.
11.7 Alfa Scientific Designs Inc.
11.8 Artron Laboratories Inc.
11.9 BioMerieux
11.10 Becton, Dickinson and Company
11.11 Qiagen N.V
11.12 Hologic
